Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Kaspar René Nielsen, Maria Rodrigo-Domingo, Rudi Steffensen, John Baech, Kim S Bergkvist, Liesbeth Oosterhof, Alexander Schmitz, Julie Støve Bødker, Preben Johansen, Ulla Vogel, Anette Vangsted, Karen Dybkær, Martin Bøgsted & Hans Erik Johnsen. (2017) Interactions between SNPs affecting inflammatory response genes are associated with multiple myeloma disease risk and survival. Leukemia & Lymphoma 58:11, pages 2695-2704.
Read now
Read now
Arianna Calcinotto, Maurilio Ponzoni, Roberto Ria, Matteo Grioni, Elena Cattaneo, Isabella Villa, Maria Teresa Sabrina Bertilaccio, Marta Chesi, Alessandro Rubinacci, Giovanni Tonon, P Leif Bergsagel, Angelo Vacca & Matteo Bellone. (2015) Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma. OncoImmunology 4:6.
Read now
Read now
Shinji Nakajima, Tohru Fujiwara, Hiroto Ohguchi, Yasushi Onishi, Mayumi Kamata, Yoko Okitsu, Noriko Fukuhara, Kenichi Ishizawa & Hideo Harigae. (2014) Induction of thymic stromal lymphopoietin in mesenchymal stem cells by interaction with myeloma cells. Leukemia & Lymphoma 55:11, pages 2605-2613.
Read now
Read now
Amit S. Khot, H. Miles Prince, Simon J. Harrison & John F. Seymour. (2014) Myeloma and pregnancy: strange bedfellows?. Leukemia & Lymphoma 55:4, pages 966-968.
Read now
Read now
Marco Rossi, Cirino Botta, Pierpaolo Correale, Pierfrancesco Tassone & Pierosandro Tagliaferri. (2013) Immunologic microenvironment and personalized treatment in multiple myeloma. Expert Opinion on Biological Therapy 13:sup1, pages S83-S93.
Read now
Read now
Ewa Bien, Malgorzata Krawczyk, Ewa Izycka-Swieszewska, Piotr Trzonkowski, Bernarda Kazanowska, Elzbieta Adamkiewicz-Drozynska & Anna Balcerska. (2013) Deregulated systemic IL-10/IL-12 balance in advanced and poor prognosis paediatric soft tissue sarcomas. Biomarkers 18:3, pages 204-215.
Read now
Read now
Articles from other publishers (30)
Ciara L. Freeman, Reginald Atkins, Indumathy Varadarajan, Meghan Menges, Jeffrey Edelman, Rachid Baz, Jason Brayer, Omar Castaneda Puglianini, Jose Leonel Ochoa-Bayona, Taiga Nishihori, Kenneth H. Shain, Bijal Shah, Dung Tsa Chen, Linda Kelley, Domenico Coppola, Melissa Alsina, Scott Antonia, Claudio Anasetti & Frederick L. Locke. (2023) Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma. Clinical Cancer Research 29:22, pages 4575-4585.
Crossref
Crossref
Yan Cheng, Fumou Sun, Daisy V. Alapat, Visanu Wanchai, David Mery, Wancheng Guo, Huojun Cao, Yuqi Zhu, Cody Ashby, Michael Anton Bauer, Intawat Nookaew, Eric R. Siegel, Jun Ying, Jin-Ran Chen, Dongzheng Gai, Bailu Peng, Hongwei Xu, Clyde Bailey, Samer Al Hadidi, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, Marta Chesi, P. Leif Bergsagel, Frits van Rhee, Siegfried Janz, Guido Tricot, John D. ShaughnessyJr.Jr. & Fenghuang Zhan. (2023) High NEK2 expression in myeloid progenitors suppresses T cell immunity in multiple myeloma. Cell Reports Medicine 4:10, pages 101214.
Crossref
Crossref
Elham Roshandel, Haniyeh Ghaffari-Nazari, Mozhdeh Mohammadian, Maryam Salimi, Saeid Abroun, Reza Mirfakhraie & Abbas Hajifathali. (2023) NK cell therapy in relapsed refractory multiple myeloma. Clinical Immunology 246, pages 109168.
Crossref
Crossref
Cinnie Yentia Soekojo & Wee Joo Chng. (2022) The evolution of immune dysfunction in multiple myeloma. European Journal of Haematology 109:5, pages 415-424.
Crossref
Crossref
Danai Dima, Dongxu Jiang, Divya Jyoti Singh, Metis Hasipek, Haikoo S. Shah, Fauzia Ullah, Jack Khouri, Jaroslaw P. Maciejewski & Babal K. Jha. (2022) Multiple Myeloma Therapy: Emerging Trends and Challenges. Cancers 14:17, pages 4082.
Crossref
Crossref
Zhigang Yi, Tao Ma, Jia Liu, Wenting Tie, Yanhong Li, Jun Bai, Lijuan Li & Liansheng Zhang. (2022) The yin–yang effects of immunity: From monoclonal gammopathy of undetermined significance to multiple myeloma. Frontiers in Immunology 13.
Crossref
Crossref
Muthulekha Swamydas, Elena V. Murphy, James J. Ignatz-Hoover, Ehsan Malek & James J. Driscoll. (2022) Deciphering mechanisms of immune escape to inform immunotherapeutic strategies in multiple myeloma. Journal of Hematology & Oncology 15:1.
Crossref
Crossref
Nikolaos Giannakoulas, Ioannis Ntanasis-Stathopoulos & Evangelos Terpos. (2021) The Role of Marrow Microenvironment in the Growth and Development of Malignant Plasma Cells in Multiple Myeloma. International Journal of Molecular Sciences 22:9, pages 4462.
Crossref
Crossref
Marie Thérèse Rubio, Adèle Dhuyser & Stéphanie Nguyen. (2021) Role and Modulation of NK Cells in Multiple Myeloma. Hemato 2:2, pages 167-181.
Crossref
Crossref
Andrea Díaz-Tejedor, Mauro Lorenzo-Mohamed, Noemí Puig, Ramón García-Sanz, María-Victoria Mateos, Mercedes Garayoa & Teresa Paíno. (2021) Immune System Alterations in Multiple Myeloma: Molecular Mechanisms and Therapeutic Strategies to Reverse Immunosuppression. Cancers 13:6, pages 1353.
Crossref
Crossref
Jessica Wenthe, Sedigheh Naseri, Ann-Charlotte Hellström, Helena Jernberg Wiklund, Emma Eriksson & Angelica Loskog. (2020) Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD40. Cancer Gene Therapy 27:12, pages 948-959.
Crossref
Crossref
Slavisa Ninkovic & Hang Quach. (2020) Shaping the Treatment Paradigm Based on the Current Understanding of the Pathobiology of Multiple Myeloma: An Overview. Cancers 12:11, pages 3488.
Crossref
Crossref
Patrizia Leone, Antonio Giovanni Solimando, Eleonora Malerba, Rossella Fasano, Alessio Buonavoglia, Fabrizio Pappagallo, Valli De Re, Antonella Argentiero, Nicola Silvestris, Angelo Vacca & Vito Racanelli. (2020) Actors on the Scene: Immune Cells in the Myeloma Niche. Frontiers in Oncology 10.
Crossref
Crossref
Paweł Robak, Edyta Węgłowska, Izabela Dróżdż, Damian Mikulski, Dariusz Jarych, Magdalena Ferlińska, Ewa Wawrzyniak, Małgorzata Misiewicz, Piotr Smolewski, Wojciech Fendler, Janusz Szemraj & Tadeusz Robak. (2020) Cytokine and Chemokine Profile in Patients with Multiple Myeloma Treated with Bortezomib. Mediators of Inflammation 2020, pages 1-13.
Crossref
Crossref
Nidhi Gupta, Aparna Sharma & Alpana Sharma. (2020) Emerging biomarkers in Multiple Myeloma: A review. Clinica Chimica Acta 503, pages 45-53.
Crossref
Crossref
Faqing Tian, Bo Lu, Ziren Chen, Junru Liu, Delan Ji, Juheng Li, Meiqin Tang, Wei Zhu & Juan Li. (2019) Microbial antigens-loaded myeloma cells enhance Th2 cell proliferation and myeloma clonogenicity via Th2–myeloma cell interaction. BMC Cancer 19:1.
Crossref
Crossref
Gianfranco Pittari, Luca Vago, Moreno Festuccia, Chiara Bonini, Deena Mudawi, Luisa Giaccone & Benedetto Bruno. (2017) Restoring Natural Killer Cell Immunity against Multiple Myeloma in the Era of New Drugs. Frontiers in Immunology 8.
Crossref
Crossref
Benjamin W. Teh, Simon J. Harrison, Cody Charles Allison, Monica A. Slavin, Tim Spelman, Leon J. Worth, Karin A. Thursky, David Ritchie & Marc Pellegrini. (2017) Predicting Risk of Infection in Patients with Newly Diagnosed Multiple Myeloma: Utility of Immune Profiling. Frontiers in Immunology 8.
Crossref
Crossref
Camille Guillerey, Kyohei Nakamura, Slavica Vuckovic, Geoffrey R. Hill & Mark J. Smyth. (2016) Immune responses in multiple myeloma: role of the natural immune surveillance and potential of immunotherapies. Cellular and Molecular Life Sciences 73:8, pages 1569-1589.
Crossref
Crossref
Min Wang, Ping Chen, Yan Jia, Na He, Daqi Li, Chunyan Ji & Daoxin Ma. (2015) Elevated Th22 as well as Th17 cells associated with therapeutic outcome and clinical stage are potential targets in patients with multiple myeloma. Oncotarget 6:20, pages 17958-17967.
Crossref
Crossref
M. Binsfeld, K. Fostier, J. Muller, F. Baron, R. Schots, Y. Beguin, R. Heusschen & J. Caers. (2014) Cellular immunotherapy in multiple myeloma: Lessons from preclinical models. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1846:2, pages 392-404.
Crossref
Crossref
Poonam Gaur, Avadhesh Kumar Singh, Nootan K. Shukla & Satya N. Das. (2014) Inter-relation of Th1, Th2, Th17 and Treg cytokines in oral cancer patients and their clinical significance. Human Immunology 75:4, pages 330-337.
Crossref
Crossref
Lei Quan, Zhihong Gong, Song Yao, Elisa V. Bandera, Gary Zirpoli, Helena Hwang, Michelle Roberts, Gregory Ciupak, Warren Davis, Lara Sucheston, Karen Pawlish, Dana H. Bovbjerg, Lina Jandorf, Citadel Cabasag, Jean-Gabriel Coignet, Christine B. Ambrosone & Chi-Chen Hong. (2014) Cytokine and cytokine receptor genes of the adaptive immune response are differentially associated with breast cancer risk in American women of African and European ancestry. International Journal of Cancer 134:6, pages 1408-1421.
Crossref
Crossref
Alessandra Romano, Concetta Conticello, Maide Cavalli, Calogero Vetro, Alessia La Fauci, Nunziatina Laura Parrinello & Francesco Di Raimondo. (2014) Immunological Dysregulation in Multiple Myeloma Microenvironment. BioMed Research International 2014, pages 1-10.
Crossref
Crossref
Jessica M. S. Jutzy, Salma Khan, Malyn May Asuncion-Valenzuela, Terry-Ann M. Milford, Kimberly J. Payne & Nathan R. Wall. (2012) Tumor-Released Survivin Induces a Type-2 T Cell Response and Decreases Cytotoxic T Cell Function, in Vitro. Cancer Microenvironment 6:1, pages 57-68.
Crossref
Crossref
Dana Cholujova, Jana Jakubikova, Branislav Czako, Michaela Martisova, Luba Hunakova, Jozef Duraj, Martin Mistrik & Jan Sedlak. (2012) MGN-3 arabinoxylan rice bran modulates innate immunity in multiple myeloma patients. Cancer Immunology, Immunotherapy 62:3, pages 437-445.
Crossref
Crossref
A.J.M. Vermorken, J. Zhu, W.J.M. Van de Ven & E. Andr?s. (2012) Curcumin for monoclonal gammopathies. What can we hope for, what should we fear?. Critical Reviews in Oncology/Hematology 84:3, pages 350-360.
Crossref
Crossref
Zahra Mojtahedi. (2012) Possible different serum IL-4 levels across populations: A reason for dissimilar incidence of Th1 and Th2 diseases. Medical Hypotheses 78:6, pages 776-777.
Crossref
Crossref
Suhasini Joshi, Rehan Khan, Manoj Sharma, Lalit Kumar & Alpana Sharma. (2011) Angiopoietin-2: A potential novel diagnostic marker in multiple myeloma. Clinical Biochemistry 44:8-9, pages 590-595.
Crossref
Crossref
S. Joshi, A.K. Tiwari, B. Mondal & A. Sharma. (2011) Oncoproteomics. Clinica Chimica Acta 412:3-4, pages 217-226.
Crossref
Crossref